Beijing Biostar Technologies Ltd announced that it will received CNY 100,000,000 in a round of funding on April 28, 2017. The transaction will include participation from new investor Betta Pharmaceuticals Co.,Ltd (SZSE:300558) for CNY 50,000,000 and other investors for CNY 50,000,000. The transaction has been approved in the 13th session of the 2nd directorate of Betta Pharmaceuticals Co.,Ltd. The round is raised at a pre-money valuation of CNY 850,000,000. Betta Pharmaceuticals Co.,Ltd will contribute CNY 1,307,815 to the registered capital and CNY 48,692,185 to capital reserve of the company. Betta Pharmaceuticals Co.,Ltd will acquire 5.2632% stake in the company through this transaction. The company reported total assets of CNY 139,062,619.69, total liabilities of CNY 738,461.73, net assets of CNY 138,324,157.96, operating revenue of CNY 175,570.58, operating loss of CNY 185,932.6, and net loss of CNY 188,208.42 for the year ended December 31, 2016.